Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FDW01
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,639
Award facts
- Contract value 100% obligated
- $16,639.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $16,639.46, represents non-competitive procurement and is scheduled for completion by November 3, 2025. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical and medical commodities to support global military healthcare operations.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal healthcare vendor with a broad portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The company's role as a DLA prime vendor positions it to support military healthcare systems, the Defense Health Agency, and other federal customers. This delivery order for Biktarvy, an antiretroviral medication used in HIV treatment regimens, exemplifies the company's role in fulfilling specialized pharmaceutical requirements within the federal medical supply chain. The contract contains no set-aside designation and represents standard competitive procurement through DLA's established pharmaceutical prime vendor framework.
Quick answers
Who was awarded contract SPE2DB26FDW01?
SPE2DB26FDW01 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FDW01 worth?
The government has obligated $16,639 on SPE2DB26FDW01.
Is contract SPE2DB26FDW01 an order under another contract?
Yes. SPE2DB26FDW01 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDW01 competed?
The extent of competition for SPE2DB26FDW01 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award